Publications - Vivek Roy, M.D.

Back to Research Profile

1. Bhatt V, Vendrell N, Nau K, Crumb D, Roy V. Implementation of a standardized protocol for prevention and management of oral mucositis in patients undergoing hematopoietic cell transplantation. J Oncol Pharm Pract 2009 Nov 12. [Epub ahead of print]
   View PubMed
2. Lacy MQ, Hayman SR, Gertz MA, Dispenzieri A, Buadi F, Kumar S, Greipp PR, Lust JA, Russell SJ, Dingli D, Kyle RA, Fonseca R, Bergsagel PL, Roy V, Mikhael JR, Stewart AK, Laumann K, Allred JB, Mandrekar SJ, Rajkumar SV. Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma. J Clin Oncol 2009 Oct 20; 27(30):5008-14. Epub 2009 Aug 31.
   View PubMed
3. Schaefer EW, Loaiza-Bonilla A, Juckett M, DiPersio JF, Roy V, Slack J, Wu W, Laumann K, Espinoza-Delgado I, Gore SD, Mayo P2C Phase II Consortium. A phase 2 study of vorinostat in acute myeloid leukemia. Haematologica 2009 Oct; 94(10):1375-82.
   View PubMed
4. Hari PN, Zhang MJ, Roy V, Perez WS, Bashey A, To LB, Elfenbein G, Freytes CO, Gale RP, Gibson J, Kyle RA, Lazarus HM, McCarthy PL, Milone GA, Pavlovsky S, Reece DE, Schiller G, Vela-Ojeda J, Weisdorf D, Vesole D. Is the international staging system superior to the Durie-Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant. Leukemia 2009 Aug; 23(8):1528-34.
   View PubMed
5. Kapoor P, Kumar S, Fonseca R, Lacy MQ, Witzig TE, Hayman SR, Dispenzieri A, Buadi F, Bergsagel PL, Gertz MA, Dalton RJ, Mikhael JR, Dingli D, Reeder CB, Lust JA, Russell SJ, Roy V, Zeldenrust SR, Stewart AK, Kyle RA, Greipp PR, Rajkumar SV. Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone. Blood 2009 Jul 16; 114(3):518-21. Epub 2009 Mar 26.
   View PubMed
6. Roy V, Perez EA. Biologic therapy of breast cancer: focus on co-inhibition of endocrine and angiogenesis pathways. Breast Cancer Res Treat 2009 Jul; 116(1):31-8. Epub 2008 Dec 20.
   View PubMed
7. Amar S, Roy V, Perez EA. Treatment of metastatic breast cancer: looking towards the future. Breast Cancer Res Treat 2009 Apr; 114(3):413-22. Epub 2008 May 09.
   View PubMed
8. Roy V, LaPlant BR, Gross GG, Bane CL, Palmieri FM, North Central Cancer Treatment Group. Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane) in combination with gemcitabine in patients with metastatic breast cancer (N0531). Ann Oncol 2009 Mar; 20(3):449-53. Epub 2008 Dec 15.
   View PubMed
9. Roy V. Artifactual laboratory abnormalities in patients with paraproteinemia. South Med J 2009 Feb; 102(2):167-70.
   View PubMed
10. Roy V, Laplant BR, Gross GG, Bane CL, Palmieri FM, for the North Central Cancer Treatment Group. Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane(R)) in combination with gemcitabine in patients with metastatic breast cancer (N0531). Ann Oncol 2008 Dec 15. [Epub ahead of print]
    View PubMed
11. Zubair AC, Grant R, Wu W, Tun H, Rivera C, Moreno-Aspitia A, Joyce M, Roy V, Colon-Otero G, Solberg LA. Platelet count is a sensitive predictor of autologous peripheral blood progenitor cell collection yield in previously treated plasma cell disease patients. Transfusion 2008 Jun; 48(6):1106-14. Epub 2008 Feb 25.
    View PubMed
12. Kumar S, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Gastineau DA, Litzow MR, Fonseca R, Roy V, Rajkumar SV, Gertz MA. Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma. Leukemia 2007 Sep; 21(9):2035-42. Epub 2007 Jun 21.
    View PubMed
13. Stewart AK, Bergsagel PL, Greipp PR, Dispenzieri A, Gertz MA, Hayman SR, Kumar S, Lacy MQ, Lust JA, Russell SJ, Witzig TE, Zeldenrust SR, Dingli D, Reeder CB, Roy V, Kyle RA, Rajkumar SV, Fonseca R. A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy. Leukemia 2007 Mar; 21(3):529-34. Epub 2007 Jan 18.
    View PubMed
14. Dispenzieri A, Rajkumar SV, Gertz MA, Fonseca R, Lacy MQ, Bergsagel PL, Kyle RA, Greipp PR, Witzig TE, Reeder CB, Lust JA, Russell SJ, Hayman SR, Roy V, Kumar S, Zeldenrust SR, Dalton RJ, Stewart AK. Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement. Mayo Clin Proc 2007 Mar; 82(3):323-41.
    View PubMed
15. Roy A, Roy V. An unusual case of prochlorperazine induced dyskinesia masquerading as stroke. Resident & Staff Physicians 2007 Feb; 53(2):45-6.
    View PubMed
16. Lacy MQ, Dispenzieri A, Gertz MA, Greipp PR, Gollbach KL, Hayman SR, Kumar S, Lust JA, Rajkumar SV, Russell SJ, Witzig TE, Zeldenrust SR, Dingli D, Bergsagel PL, Fonseca R, Reeder CB, Stewart AK, Roy V, Dalton RJ, Carr AB, Kademani D, Keller EE, Viozzi Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma. Mayo Clin Proc 2006 Aug; 81(8):1047-53.
    View PubMed
17. Valente M, Roy V, Lacy MQ, Dispenzieri A, Gertz MA. Autologous stem cell transplantation and IgM amyloidosis. Leuk Lymphoma 2006 Jun; 47(6):1006-12.
    View PubMed
18. Roy A, Roy V. Primary systemic amyloidosis. Early diagnosis and therapy can improve survival rates and quality of life. Postgrad Med 2006 Jun-Jul; 119(1):93-9.
    View PubMed
19. Roy V, Perez EA. New therapies in the treatment of breast cancer. Semin Oncol 2006 Jun; 33(3 Suppl 9):S3-8.
    View PubMed
20. Sekhon SS, Roy V. Thrombocytopenia in adults: A practical approach to evaluation and management. South Med J 2006 May; 99(5):491-8; quiz 499-500, 533.
    View PubMed
21. Roy V, Perez EA. Adjuvant docetaxel plus doxorubicin and cyclophosphamide increases survival compared with fluorouracil plus doxorubicin and cyclophosphamide in women with operable node-positive breast cancer. Cancer Treat Rev 2006 Feb; 32(1):55-8. Epub 2006 Jan 19.
    View PubMed
22. Roy A, Heckman MG, Roy V. Associations between the hospitalist model of care and quality-of-care-related outcomes in patients undergoing hip fracture surgery. Mayo Clin Proc 2006 Jan; 81(1):28-31.
    View PubMed
23. Roy A, Roy V. Using beta-blocker to cut perioperative risk in CAD. [Turkish]. SENDROM 2006; 18(12):42-5.
    View PubMed
24. Roy A, Roy V. Using beta-blockers to cut perioperative risk in CAD. Cardioprotective strategies for noncardiac surgery. Postgrad Med 2005 Dec; 118(6):34-6, 41-2.
    View PubMed
25. Roy A, Gisel JJ, Roy V, Bouras EP. Superior mesenteric artery (Wilkie's) syndrome as a result of cardiac cachexia. J Gen Intern Med 2005 Oct; 20(10):C3-4.
    View PubMed
26. Pavletic SZ, Khouri IF, Haagenson M, King RJ, Bierman PJ, Bishop MR, Carston M, Giralt S, Molina A, Copelan EA, Ringden O, Roy V, Ballen K, Adkins DR, McCarthy P, Weisdorf D, Montserrat E, Anasetti C. Unrelated donor marrow transplantation for B-Cell chronic lymphocytic leukemia after using myeloablative conditioning: Results from the center for international blood and marrow transplant research. J Clin Oncol 2005 Aug 20; 23(24):5788-94.
    View PubMed
27. Roy V, Perez WS, Eapen M, Marsh JCW, Pasquini M, Pasquini R, Mustafa MM, Bredeson CN. Bone marrow transplantation for Diamond-Blackfan anemia. Biol Blood Marrow Transplant 2005 Aug; 11(8):600-8.
    View PubMed
28. Dispenzieri A, Moreno-Aspitia A, Suarez GA, Lacy MQ, Colon-Otero G, Tefferi A, Litzow MR, Roy V, Hogan WJ, Kyle RA, Gertz MA. Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome: and a review of the literature. Blood 2004 Nov 15; 104(10):3400-7.
    View PubMed
29. Whitehead RP, Lew D, Flanigan RC, Weiss GR, Roy V, Glode ML, Dakhil SR, Crawford ED. Phase II trial of recombinant human interleukin-4 in patients with advanced renal cell carcinoma: a Southwest Oncology Group study. J Immunother 2002 Jul-Aug; 25(4):352-8.
    View PubMed
30. Flanigan RC, Salmon SE, Blumenstein BA, Bearman SI, Roy V, McGrath PC, Caton JR Jr, Munshi N, Crawford ED. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 2001 Dec 6; 345(23):1655-9.
    View PubMed
31. Roy V, Rizvi MA, Vesely SK, George JN. Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes. Bone Marrow Transplant 2001 Mar; 27(6):641-6.
    View PubMed
32. Petersdorf SH, Kopecky KJ, Head DR, Boldt DH, Balcerzak SP, Wun T, Roy V, Veith RW, Appelbaum FR. Comparison of the L10M consolidation regimen to an alternative regimen including escalating methotrexate/L-asparaginase for adult acute lymphoblastic leukemia: a Southwest Oncology Group Study. Leukemia 2001 Feb; 15(2):208-16.
    View PubMed
33. Roy V, Ali LI, Carter TH, Selby GB. Successful non-surgical treatment of disseminated polymicrobial fungal infection in a patient with pancytopenia and graft-versus-host disease. J Infect 2000 Nov; 41(3):273-5.
    View PubMed
34. Roy V, Ali LI, Selby GB. Routine chest radiography for the evaluation of febrile neutropenic patients after autologous stem cell transplantation. Am J Hematol 2000 Jul; 64(3):170-4.
    View PubMed
35. Fisher RI, Dana BW, LeBlanc M, Kjeldsberg C, Forman JD, Unger JM, Balcerzak SP, Gaynor ER, Roy V, Miller T. Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809. J Clin Oncol 2000 May; 18(10):2010-6.
    View PubMed
36. Abang AM, Takemoto MH, Pham T, Mandanas RA, Roy V, Selby GB, Carter TH. Efficacy and safety of oral granisetron versus i.v. granisetron in patients undergoing peripheral blood progenitor cell and bone marrow transplantation. Anticancer Drugs 2000 Feb; 11(2):137-42.
    View PubMed
37. Roy V, Verfaillie CM. Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitors: implications for anatomical localization and developmental stage specific regulation of hematopoiesis. Exp Hematol 1999 Feb; 27(2):302-12.
    View PubMed
38. Mandanas RA, Carter TH, Epstein RB, Roy V, Selby GB. Marrow and stem cell transplantation in Oklahoma: fifteen years of experience and results. J Okla State Med Assoc 1998 Sep; 91(6):339-46.
    View PubMed
39. Roy V, Verfaillie CM. Soluble factor(s) produced by adult bone marrow stroma inhibit in vitro proliferation and differentiation of fetal liver BFU-E by inducing apoptosis. J Clin Invest 1997 Aug 15; 100(4):912-20.
    View PubMed
40. Roy V, Ochs L, Weisdorf D. Late infections following allogeneic bone marrow transplantation: suggested strategies for prophylaxis. Leukemia & Lymphoma 1997 Jun; 26(1-2):1-15.
    View PubMed
41. Roy V, Miller JS, Verfaillie CM. Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver. Exp Hematol 1997 May; 25(5):387-94.
    View PubMed
42. Roy V, Weisdorf D. Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review. Bone Marrow Transplant 1997 Mar; 19(5):467-70.
    View PubMed
43. Verfaillie CM, Bhatia R, Miller W, Mortari F, Roy V, Burger S, McCullough J, Stieglbauer K, Dewald G, Heimfeld S, Miller JS, McGlave PB. BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients. Blood 1996 Jun 1; 87(11):4770-9.
    View PubMed
44. Roy V, Verfaillie CM. Refractory thrombocytopenia due to anti-PLA1 antibodies following autologous peripheral blood stem cell transplantation: case report and review of literature. Bone Marrow Transplant 1996 Jan; 17(1):115-7.
    View PubMed
45. Roy V, Veys P, Jackson F, Ryan J, Lowdell M, Newland AC. Adult respiratory syndrome following autologous bone marrow transfusion. Bone Marrow Transplant 1989 Nov; 4(6):711-2.
    View PubMed
46. Roy V, Gutteridge CN, Nysenbaum A, Newland AC. Combination chemotherapy with conservative obstetric management in the treatment of pregnant patients with acute myeloblastic leukaemia. Clinical & Laboratory Haematology 1989; 11(3):171-8.
    View PubMed
47. Roy V, Tillyer ML, Colvin BT. Acute abdominal pain due to an acquired disorder of coagulation. Br Med J (Clin Res Ed) 1988 May 21; 296(6634):1460.
    View PubMed
48. Dispenzieri A, Rajkumar SV, Gertz MA, Fonseca R, Lacy MQ, Bergsagel PL, Kyle RA, Greipp PR, Witzig TE, Reeder CB, Lust JA, Russell SJ, Hayman SR, Roy V, Kumar S, Zeldenrust SR, Dalton RJ, Stewart AK. Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement. Mayo Clin Proc 2007 Mar; 82(3):323-41.
    View PubMed